ENDPOINTS

#ASCO25: Volastra unveils first human data of its oral ...

Volastra Therapeutics has been bullish about KIF18A as a solid tumor drug target...

#ASCO25: Merus’ Phase 2 overall survival data reach ‘ho...

Merus completed its rollout of Phase 2 head and neck cancer data on Thursday, to...

GSK’s Nucala wins COPD approval, stoking rivalry with D...

GSK’s blockbuster respiratory drug Nucala was approved Thursday for certain pati...

#ASCO25: Jazz outlines full survival data for lung canc...

A drug from Jazz Pharmaceuticals that has yet to read out confirmatory data in l...

#ASCO25: Roche confirms OS benefit for PI3K inhibitor I...

The final overall survival results are in for Roche’s PI3K inhibitor, known as I...

Hinge Health popped as the digital health IPO market re...

Hinge Health shares {$HNGE} ended its first day of trading up 18%, setting the t...

FDA vaccine advisors update Covid strain guidance follo...

Almost two years ago, Vinay Prasad called a meeting of FDA vaccine advisors a “s...

House passes Trump tax bill with PBM and orphan drug re...

The House of Representatives on Thursday morning passed President Donald Trump’s...

Makary to senators: FDA staff cuts won't delay user fee...

FDA Commissioner Marty Makary defended thousands of staff cuts during his first ...

Hinge Health pops 23% as the digital health IPO market ...

Hinge Health shares {$HNGE} jumped 23% in its first day trading as a public comp...

Cigna, Novo Nordisk offer lower GLP-1 prices

The sun is setting on compounding pharmacies’ ability to make copies of hot weig...

FDA names acting head of inspections; J&J again advocat...

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential ne...

The ‘MAHA report’: What it says about vaccines, medicin...

The White House released its MAHA Commission report, detailing some of the Trump...

An unpredictable year for healthcare

Every year, the venture firm Venrock conducts its annual “Healthcare Prognosis” ...

Endpoints News is getting a new web address https://end...

Endpoints News is moving to a new website domain on June 1, 2025. The front door...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.